Health

Duoning maintains supply chain stability with operation of factory in Wuxi

SHANGHAI, Dec. 29, 2022 /PRNewswire/ -- Wuxi Duoning Factory, one of the seven manufacturing sites owned by Duoning Biotechnology, has been put into operation recently. The factory, through producing culture media and filters, is designed to provide optimal and quality-controlled bioprocess solut...

2022-12-29 20:00 2627

Qilu Pharmaceutical Announces Progress of Clinical Study of QL1706, an Innovative Bifunctional Antibody

JINAN, China, Dec. 29, 2022 /PRNewswire/ -- In 2022, Qilu Pharmaceutical revealed the latest progress being made with several clinical studies involving its innovativebifunctional antibody, QL1706, at several international and Chinese academic conferences, including the American Association for C...

2022-12-29 14:32 1706

CGTN: Vitality under COVID-19: China's smart ports aid increased throughput

BEIJING, Dec. 29, 2022 /PRNewswire/ -- China's Qingdao Port, a subsidiary of Shandong Port Group and the second-largest foreign trade port in eastChina's Shandong Province, has seen an increase in anchorage rotations of very large container ships, according to China Media Group. The port has han...

2022-12-29 11:55 6941

A Korean DTx Company LifeSemantics to Unveil the Redpill Breath Solution for Pulmonary Rehabilitation DTx at CES 2023

* LifeSemantics will participate in the Digital Healthcare section of CES 2023 and unveil theRedpill Breath Solution, a pulmonary rehabilitation DTx. * The company will open a booth at the Korean pavilion in Eureka Park and offer an opportunity to experience the solution. * LifeSemantics wil...

2022-12-28 22:00 2045

Global Times: Three years' hard effort to fight COVID-19 'worthwhile'

BEIJING, Dec. 28, 2022 /PRNewswire/ -- After three years' hard effort to keep the COVID-19 at bay,China has optimized its virus responses recently. The Global Times has talked with front line medical workers, grass-roots community workers and others about their experience in the three-year battle...

2022-12-28 21:38 1989

China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask

HAIKOU, China, Dec. 28, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma", the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced the launch of N95 medical protect...

2022-12-28 21:00 2276

WeTrade Group and Kunyue Medical Reached Cooperation Online Store "Epidemic Inspection Pass" has Achieved a Daily Average of 50,000+ Online Sales Orders

BEIJING, Dec. 28, 2022 /PRNewswire/ -- WeTrade Group Inc. ("WeTrade" or the "Company") (NASDAQ: WETG), a global diversified "software as a service" ("SaaS") technology service provider committed to providing technical support and digital transformation tools for enterprises across different indus...

2022-12-28 20:53 2399

Takeda Healthcare Philippines Inc Honored the Inspirational Award at the Asia Pacific Enterprise Awards 2022 Regional Edition

SINGAPORE, Dec. 28, 2022 /PRNewswire/ -- Enterprise Asia, the organizer of the Asia Pacific Enterprise Awards (APEA) 2022 Regional Edition, is pleased to recognize 25 exemplary business leaders and enterprises acrossAsia which excelled and showcased unparalleled resilience and growth despite theC...

2022-12-28 15:30 2285

SAVEWO introduces the only Hong Kong-made respirator obtaining top EU and China certifications, enters medical market with increased investment and production capacity

HONG KONG, Dec. 28, 2022 /PRNewswire/ -- While the COVID-19 pandemic stabilises inHong Kong and many resume normal life, Hong Kong-based mask developer and manufacturer SAVEWO plans to increase investment and production capacity, pivoting from masks for the mass to the professional medical grade ...

2022-12-28 11:00 2628

Everest Medicines Commences Operations at its mRNA Vaccine Manufacturing Facility, Accelerating Evolution to a Fully-Integrated Biopharma

--Everest owns complete pharmaceutical and vaccine value chain from discovery, clinical development, manufacturing and commercialization-- --Localizes company's mRNA vaccine production, and helps meet urgent China and global demand for innovative vaccines and medicines-- SHANGHAI, Dec. 28, 2022 ...

2022-12-28 08:00 2895

CGTN: Vitality under COVID-19: China gears up for medical supplies

BEIJING, Dec. 28, 2022 /PRNewswire/ -- China has made efforts to ensure the medical supplies needed for COVID-19 prevention and control after it loosened its epidemic measures in early December, which was followed by an increase in infections and surging demand for medicines. The country's Natio...

2022-12-28 00:13 6690

Non-invasive in vitro diagnostic (IVD) test enables early detection of colorectal cancer

SAO PAULO, Brazil, Dec. 27, 2022 /PRNewswire/ -- The DNA Methylation Detection Kit for Human SDC2, ADHFE1 and PPP2R5C Genes (Real-Time PCR), the colorectal cancer early detection product under BGI's wholly-owned subsidiary BGI Biotechnology (Wuhan) Co., Ltd., has recently obtained the medical dev...

2022-12-27 23:59 2100

The Top 3 Best Places to Work in Indonesia for 2022 revealed

JAKARTA, Indonesia, Dec. 27, 2022 /PRNewswire/ -- Novo Nordisk, AstraZeneca and Jardine Schindler Indonesia are recognized as the top 3 best places to work in Indonesia for 2022 according to the annual prestigious "Best Places to Work" certification program. Best Places to Work is an international...

2022-12-27 21:39 2389

Waterdrop Listed among Beijing's Top 100 Enterprises in Digital Economy

BEIJING, Dec. 27, 2022 /PRNewswire/ -- Recently, Beijing Enterprise Confederation and Beijing Entrepreneurs Association released the Top 100 Enterprises inBeijing list (the List) and the Report on the Development of the Top 100 Enterprises inBeijing (the Report) at the Beijing International Conv...

2022-12-27 21:00 2715

Promising Singaporean Medtech Firm Osteopore Achieves Record Revenue, Enters New Markets and Operates in All Major Continents in 2022

SINGAPORE, Dec. 27, 2022 /PRNewswire/ -- Singapore-based Medtech Firm Osteopore announces their record revenue of$460,684 for Q3 CY22, an increase of 6.6% over the preceding quarter. As an extension of the same financial year, Osteopore has likewise broadened their regional operations to spanColo...

2022-12-27 20:37 3057

Brii Biosciences Provides Update on Strategic Clinical Development Progress

Topline Phase 2 data from multiple hepatitis B viral (HBV) infection functional cure combination studies expected in the first half of 2023 Initiation of Phase 2 postpartum depression (PPD) study planned for early 2023 to advance potential first-of-its-kind treatment U.S. FDA lifted clinical hol...

2022-12-27 20:00 2788

China to downgrade COVID-19 management to Class B

BEIJING, Dec. 27, 2022 /PRNewswire/ -- A report from People's Daily: China will downgrade management of COVID-19 to Class B and cancel quarantine requirements on inbound travelers fromJan. 8, 2023, China's top health authority announced recently. In a statement released late Monday, the National...

2022-12-27 18:06 2269

EOFlow Submits Application to the U.S. FDA for its Wearable Insulin Pump 'EOPatch'

* Plans to finalize its U.S. distribution strategy in 2023 * Aims to enter the U.S., the world's largest diabetes market, with its current disposable wearable insulin pump 'EOPatch' SAN JOSE, Calif. , Dec. 27, 2022 /PRNewswire/ -- EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a p...

2022-12-27 15:48 1764

Ablaze Pharmaceuticals and Yonghe Pharma Initiate Development and Manufacturing Services Agreement for Targeted Radiopharmaceutical Therapies

SHANGHAI, Dec. 27, 2022 /PRNewswire/ -- Ablaze Pharmaceuticals ("Ablaze") announced the initiation of a development and manufacturing services agreement with Yonghe Pharmaceutical Technology Co., Ltd. ("Yonghe") to develop series of targeted radiopharmaceutical therapy ("TRT") products. Under the...

2022-12-27 10:00 2577

Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug 'PAXLOVID' to receive WHO Prequalification

* Hetero's 'Nirmacom' (Nirmatrelvir), a generic version of Pfizer's COVID-19 oral antiviral drug 'PAXLOVID' is co-packaged with ritonavir tablets * With the launch of Nirmacom, Hetero aims to expand access of the ground-breaking antiviral in 95 LMICs including India HYDERABAD, India, Dec. 27, ...

2022-12-27 10:00 3388
1 ... 221222223224225226227 ... 820